Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms

被引：8
|
作者：
Yung, Yammy [1 ]
Lee, Emily [1 ]
Chu, Hiu-Tung [1 ]
Yip, Pui-Kwan [1 ]
Gill, Harinder [1 ]
机构：
[1] Univ Hong Kong, LKS Fac Med, Dept Med, Div Haematol Med Oncol & Haemopoiet Stem Cell Tra, Hong Kong, Peoples R China
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2021年 / 22卷 / 02期
关键词：
stem cells; chronic myeloid leukemia; myeloproliferative neoplasm; targeted therapy; TYROSINE KINASE INHIBITORS; BONE-MARROW MICROENVIRONMENT; MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; HISTONE DEACETYLASE INHIBITORS; HYPOXIA-INDUCIBLE FACTORS; PHASE-II TRIAL; INTERFERON-ALPHA; OPEN-LABEL; TELOMERASE INHIBITOR; POLYCYTHEMIA-VERA;
D O I：
10.3390/ijms22020659
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Myeloproliferative neoplasms (MPNs) are unique hematopoietic stem cell disorders sharing mutations that constitutively activate the signal-transduction pathways involved in haematopoiesis. They are characterized by stem cell-derived clonal myeloproliferation. The key MPNs comprise chronic myeloid leukemia (CML), polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). CML is defined by the presence of the Philadelphia (Ph) chromosome and BCR-ABL1 fusion gene. Despite effective cytoreductive agents and targeted therapy, complete CML/MPN stem cell eradication is rarely achieved. In this review article, we discuss the novel agents and combination therapy that can potentially abnormal hematopoietic stem cells in CML and MPNs and the CML/MPN stem cell-sustaining bone marrow microenvironment.
引用
收藏
页码：1 / 43
页数：39
相关论文
共 50 条
  • [1] Epidemiology of the Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms
    Shallis, Rory M.
    Zeidan, Amer M.
    Wang, Rong
    Podoltsev, Nikolai A.
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (02) : 177 - 189
  • [2] Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency
    Michael J. Hochman
    B. Douglas Smith
    Theodoros Karantanos
    Evan M. Braunstein
    Ivana Gojo
    Tania Jain
    Michael B. Streiff
    Alison R. Moliterno
    Amy E. DeZern
    [J]. International Journal of Hematology, 2023, 117 : 456 - 462
  • [3] Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency
    Hochman, Michael J.
    Smith, B. Douglas
    Karantanos, Theodoros
    Braunstein, Evan M.
    Gojo, Ivana
    Jain, Tania
    Streiff, Michael B.
    Moliterno, Alison R.
    DeZern, Amy E.
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (03) : 456 - 462
  • [4] Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group
    Harinder Gill
    Garret M. K. Leung
    Melissa G. M. Ooi
    Winnie Z. Y. Teo
    Chieh-Lee Wong
    Chul Won Choi
    Gee-Chuan Wong
    Zhentang Lao
    Ponlapat Rojnuckarin
    Ma. Rosario Irene D. Castillo
    Zhijian Xiao
    Hsin-An Hou
    Ming-Chung Kuo
    Lee-Yung Shih
    Gin-Gin Gan
    Chien-Chin Lin
    Wee-Joo Chng
    Yok-Lam Kwong
    [J]. Clinical and Experimental Medicine, 2023, 23 : 4199 - 4217
  • [5] Management of classical Philadelphia chromosome-negative myeloproliferative neoplasms in Asia: consensus of the Asian Myeloid Working Group
    Gill, Harinder
    Leung, Garret M. K.
    Ooi, Melissa G. M.
    Teo, Winnie Z. Y.
    Wong, Chieh-Lee
    Choi, Chul Won
    Wong, Gee-Chuan
    Lao, Zhentang
    Rojnuckarin, Ponlapat
    Castillo, Ma. Rosario Irene D.
    Xiao, Zhijian
    Hou, Hsin-An
    Kuo, Ming-Chung
    Shih, Lee-Yung
    Gan, Gin-Gin
    Lin, Chien-Chin
    Chng, Wee-Joo
    Kwong, Yok-Lam
    [J]. CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (08) : 4199 - 4217
  • [6] Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms
    Holmstrom, Morten Orebo
    Hasselbalch, Hans Carl
    Andersen, Mads Hald
    [J]. CANCERS, 2020, 12 (07) : 1 - 21
  • [7] Impact of Comorbidities in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Ahmed, Shima A.
    Aly, Mai M.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S336 - S336
  • [8] Somatic Mutations in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms
    Cristina, Sergio Ferreira
    Polo, Blanca
    Lacerda, Joao F.
    [J]. SEMINARS IN HEMATOLOGY, 2018, 55 (04) : 215 - 222
  • [9] Concurrent lymphoid and Philadelphia chromosome-negative myeloproliferative neoplasms
    Miguel Torregrosa, Jose
    Soler, Gloria
    Cancio, Shirley
    Ferrer-Marin, Francisca
    [J]. MEDICINA CLINICA, 2015, 145 (07): : 318 - 319
  • [10] Philadelphia Chromosome-Negative Chronic Myeloproliferative Disease
    Thiele, Juergen
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 132 (02) : 261 - 280
12345